Melanoma Clinical Trials in Dallas

Showing 221-236 of 236 trials

A Study of Volociximab in Metastatic Melanoma

NCT00369395

This is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma. The purpose of the study is to compare the clinical benefit and safety of volociximab. Pharmacokinetics and mechanism of action will also be evaluated.

Stage IV Melanoma

Abbott19 participantsStarted Dec 2006

Scottsdale, Arizona, United States • La Jolla, California, United States • Aurora, Colorado, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

NCT00518895

This study is being performed to prospectively determine whether dacarbazine plus Genasense is significantly better than dacarbazine plus placebo in chemotherapy-naive patients with advanced melanoma and low baseline LDH (LDH less than or equal to 0.8 times the upper limit of normal). LDH is a biomarker strongly associated with improved outcomes in a recent trial of dacarbazine plus Genasense.

Melanoma

Genta Incorporated300 participantsStarted Jul 2007

Mobile, Alabama, United States • Encinitas, California, United States • Santa Rosa, California, United States +74 more locations

A Study of Volociximab in Metastatic Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Melanoma Trials in Other Cities

Study of XL281 in Adults With Solid Tumors

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

TNFerade™ Biologic Plus Radiation for Metastatic Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

CP-675,206 In Patients With Advanced Melanoma

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Study of CP-675,206 in Refractory Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Other Conditions in Dallas